Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Cuisinart launches the CleanWater Countertop Filtration System to reduce dependency on plastic water bottles

The Container Recycling Institute reports that Americans will buy an estimated 34.6 billion single-serve (1 liter or less) plastic water bottles in 2009. More than 75 percent of those bottles will end up in landfills or incinerators, rather than being recycled. That’s 877 bottles wasted every second, according to the Institute.

10 Nov 2009

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.

10 Nov 2009

Fun and creativity with Sick Day Survival Kit

Flu season officially begins this month, and many kids are already sneezing and coughing their way home from school early. While health officials can guide parents about how to care for their sick children, they cannot help with another pressing issue on most parents’ minds – “how am I going to entertain my sick child for an entire week at home?”

10 Nov 2009

AMP's four-day event on the latest advances in clinical molecular diagnostics

The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.

10 Nov 2009

Prolonged ED wait time is associated with poor clinical outcomes

One in four emergency department patients in 2006 waited longer to be evaluated by a clinician than recommended at triage, an increase from one in five in 1997, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Nov 2009

Activating TAp63 protein, a viable anti-cancer strategy

Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53. As a critical anti-cancer watchdog, p53 masterminds several cancer-fighting operations within cells. When cells lose p53, tumors grow aggressively and often cannot be treated.

10 Nov 2009

New N95 respirator from Safe Life

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection.

10 Nov 2009

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

Hard To Treat Diseases (HTDS.PK) www.htdsmedical.com, announced today that Novartis, a US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 million.

10 Nov 2009

Affordable health care can save millions of women, newborns, and children in sub-Saharan Africa

The lives of almost 4 million women, newborns, and children in sub-Saharan Africa could be saved every year if well-established, affordable health care interventions reached 90 percent of families, according to a joint report by the national science academies of seven African countries.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

Third quarter 2009 financial results announced by Akorn

Akorn, Inc. a specialty pharmaceutical company, today reported financial results for the third quarter ended September 30, 2009.

10 Nov 2009

Flu-Ease provides flu shots at airports

First there was a shot and a beer, then the "shot heard around the world," and now it’s a shot on the fly. The most useful airport amenity available to air travelers this season may turn out to be flu shots.

10 Nov 2009

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. "In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing," the agency said. "Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island," the news service writes (Nebehay, 11/6).

10 Nov 2009

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc. (NYSE: HUM), encourages TRICARE South Region beneficiaries to get their H1N1 influenza vaccinations in an effort to reduce the spread of the virus. Anticipating a greater need for the shots, the Department of Defense (DoD) is encouraging all military personnel to obtain the vaccines.

9 Nov 2009

NanoViricides to present data on its in vivo studies against influenza

NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment.

9 Nov 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Most patients with hereditary angioedema (HAE) have prodromal symptoms that signal an oncoming HAE attack giving the patients sufficient time to initiate treatment and decrease the morbidity associated with that attack, according to survey findings presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting.

9 Nov 2009

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.

7 Nov 2009

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

7 Nov 2009

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

Three leading scientific organizations specializing in infectious diseases prevention issued a letter to President Obama today expressing their significant concern with current federal guidance concerning the use of personal protective equipment (PPE) by healthcare workers in treating suspected or confirmed cases of 2009 H1N1 influenza.

7 Nov 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Cuisinart launches the CleanWater Countertop Filtration System to reduce dependency on plastic water bottles

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Fun and creativity with Sick Day Survival Kit

AMP's four-day event on the latest advances in clinical molecular diagnostics

Prolonged ED wait time is associated with poor clinical outcomes

Activating TAp63 protein, a viable anti-cancer strategy

New N95 respirator from Safe Life

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

Affordable health care can save millions of women, newborns, and children in sub-Saharan Africa

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

Third quarter 2009 financial results announced by Akorn

Flu-Ease provides flu shots at airports

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

NanoViricides to present data on its in vivo studies against influenza

Cellular mechanisms that may impact immune functions in the elderly discovered

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in